Features of hepcidin expression in patients with breast cancer
Saved in:
| Date: | 2015 |
|---|---|
| Main Authors: | Yu. Lukianova, T. M. Yalovenko, V. F. Chekhun |
| Format: | Article |
| Language: | English |
| Published: |
2015
|
| Series: | Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000465451 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)
by: L. A. Nalieskina, et al.
Published: (2018)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)
by: Lyalkin, S.A., et al.
Published: (2023)
Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)
by: L. A. Nalieskina, et al.
Published: (2017)
The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
by: Timovska, Yu., et al.
Published: (2011)
by: Timovska, Yu., et al.
Published: (2011)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
Surgery features in the treatment of patients with HER2-neu positive breast cancer
by: I. Y. Halaichuk
Published: (2020)
by: I. Y. Halaichuk
Published: (2020)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)
by: L. A. Tashireva, et al.
Published: (2015)
The ways to optimize the treatment of patients with regional breast cancer
by: V. H. Dubinina, et al.
Published: (2017)
by: V. H. Dubinina, et al.
Published: (2017)
Study of trace elements status of breast cancer patients
by: M. N. Tillashaykhov, et al.
Published: (2017)
by: M. N. Tillashaykhov, et al.
Published: (2017)
Study of trace elements status of breast cancer patients
by: Tillashaykhov, M.N, et al.
Published: (2017)
by: Tillashaykhov, M.N, et al.
Published: (2017)
Superroxide radicals: initiation of metastases in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2017)
by: A. P. Burlaka, et al.
Published: (2017)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Modern algorithm of treatment of patients with breast cancer and metastases in bone
by: O. V. Ponomareva, et al.
Published: (2015)
by: O. V. Ponomareva, et al.
Published: (2015)
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Ürün, Y., et al.
Published: (2015)
by: Ürün, Y., et al.
Published: (2015)
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018)
by: D. E. Ryspayeva
Published: (2018)
Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)
by: Ju. Ju. Belevtsova
Published: (2019)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: L. E. Fishchuk, et al.
Published: (2013)
by: L. E. Fishchuk, et al.
Published: (2013)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)
by: Fishchuk, L.E., et al.
Published: (2013)
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Y. Ьrьn, et al.
Published: (2015)
by: Y. Ьrьn, et al.
Published: (2015)
The features of reproductive function in women with breast cancer
by: S. E. Ragimzade
Published: (2016)
by: S. E. Ragimzade
Published: (2016)
Similar Items
-
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016) -
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018) -
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018) -
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016) -
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)